Dergiler / Turkish Journal of Medical Sciences / 2018 / Cilt: 48 - Sayı: 6

The diagnostic role of pentraxin-3 in the differential diagnosis of pleural effusions

Sayfa
1167–1174
Yayın Tarihi
2018-12-12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

These results may suggest that PTX-3 is a local acute-phase reactant and may allow discrimination of PPE from other exudative effusions.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/aim: Discrimination of pleural effusion etiology is not always easy in clinical practice.
📊
Temel Bulgular & Veri:Pentraxin-3 (PTX-3) is a new acute- phase protein.
💡
Sonuç & Katkı:These results may suggest that PTX-3 is a local acute-phase reactant and may allow discrimination of PPE from other exudative effusions.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Pleural effusion · pentraxin-3 · transudates

Abstract

Background/aim: Discrimination of pleural effusion etiology is not always easy in clinical practice. Pentraxin-3 (PTX-3) is a new acute- phase protein. The aim of this study was to investigate the role of PTX-3 in the differential diagnosis of pleural effusions. Materials and methods: This prospective study enrolled all consecutive patients from two tertiary hospitals who underwent diagnostic or therapeutic thoracentesis. In a cohort of 149 subjects with pleural effusion, including transudates and malignant (MPE), tuberculous (TPE), and parapneumonic effusion (PPE), serum and pleural effusion PTX-3 concentration measurements were performed using ELISA. Serum and pleural effusion protein, lactate dehydrogenase, C-reactive protein (CRP), and adenosine deaminase levels were also assessed. Results: Of these patients, 34 had transudates, 29 had PPE, 63 had MPE, and 23 had TPE. There was a weak correlation between pleural effusion PTX-3 level and serum CRP (P < 0.01). There was a significant difference in pleural PTX-3 levels between the exudative effusion groups (P < 0.01). The median pleural effusion PTX-3 was significantly higher in patients with PPE (11.2 ng/mL, 2-17.8) than MPE (4.7 ng/mL, 1.8-13.9) and TPE (3.1 ng/mL, 2.0-4.1). At a cut-off point of 5.89 ng/mL, PTX-3 had the best discriminatory power for PPE versus other exudative effusions (sensitivity: 86.2%, specificity: 87.7%). The exudative effusion group had a significantly different pleural effusion/serum PTX-3 ratio (P = 0.03). Conclusion: PTX-3 concentration in pleural effusion was elevated without a significant correlation with serum PTX-3 in PPE. These results may suggest that PTX-3 is a local acute-phase reactant and may allow discrimination of PPE from other exudative effusions.

🔖

Bu Makaleye Atıf Yap

ÇİFTCİ, F., BİLGİN, G., ÖZCAN, A. N., DOĞAN, Ö., YÜKSEL, A., EROL, S., ÇİLEDAĞ, A., KAYA, A. (2018). The diagnostic role of pentraxin-3 in the differential diagnosis of pleural effusions. Turkish Journal of Medical Sciences, Cilt: 48 - Sayı: 6, 1167–1174. https://ajindex.com/articles/113843

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Sahn SA, Heffner JE. Pleural fluid analysis. In: Light RW, Lee YCG, editors. Textbook of Pleural Diseases. 2nd ed. London, UK: Arnold Press; 2008. pp. 26-27.
  2. Marel M, Zrustova M, Stasny B, Light RW. The incidence of pleural effusion in a well-defined region: epidemiologic study in central Bohemia. Chest 1993; 104: 1486-1489.
  3. Hooper C, Lee YC, Maskell N; BTS Pleural Guideline Group. Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65: 4-17. Light RW. Clinical practice: pleural effusion. N Engl J Med 2002; 346: 1971-1977.
  4. Yilmaz Turay U, Yildirim Z, Turkoz Y, Biber C, Erdogan Y, Keyf AI, Uğurman F, Ayaz A, Ergün P, Harputluoğlu M. Use of pleural fluid C-reactive protein in diagnosis of pleural effusions. Respir Med 2000; 94: 432-435.
  5. Bottazzi B, Bastone A, Doni A, Garlanda C, Valentino S, Deban L, Maina V, Cotena A, Moalli F, Vago L et al. The long pentraxin PTX3 as a link among innate immunity, inflammation, and female fertility. J Leukoc Biol 2006; 79: 909-912.
  6. Wisniewski HG, Vilcek J. Cytokine-induced gene expression at the crossroads of innate immunity, inflammation and fertility: TSG-6 and PTX3/TSG-14. Cytokine Growth Factor Rev 2004; 15: 129-146.
  7. Introna M, Alles VV, Castellano M, Picardi G, De Gioia L, Bottazzai B, Peri G, Breviario F, Salmona M, De Gregorio L et al. Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites. Blood 1996; 87: 1862-1872.
  8. Camozzi M, Zacchigna S, Rusnati M, Coltrini D, Ramirez- Correa G, Bottazzi B, Mantovani A, Giacca M, Presta M. Pentraxin 3 inhibits fibroblast growth factor 2-dependent activation of smooth muscle cells in vitro and neointima formation in vivo. Arterioscler Thromb Vasc Biol 2005; 25: 1837-1842.
  9. Jaillon S, Peri G, Delneste Y, Frémaux I, Doni A, Moalli F, Garlanda C, Romani L, Gascan H, Bellocchio S et al. The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. J Exp Med 2007; 204: 793-804.
  10. Ozsu S, Abul Y, Mentese A, Bektas H, Uzun A, Ozlu T, Porcel JM. Pentraxin-3: a novel biomarker for discriminating parapneumonic from other exudative effusions. Respirology 2013; 18: 657-662.
  11. Yeo CD, Kim JW, Cho MR, Kang JY, Kim SJ, Kim YK, Lee SH, Park CK, Kim SH, Park MS et al. Pleural fluid pentraxin-3 for the differential diagnosis of pleural effusions. Tuberc Respir Dis 2013; 75: 244-249.
  12. Dickstein K, Cohen-Solal A, Filippatos G, McMurray J